Sama Fertility
Cynthia Hudson is a prominent figure in the fertility industry, currently serving as a Founding Partner at both NOVA Genomics and Perch Fertility since January 2025. In addition, Cynthia holds positions as President and President-Elect of the New England Fertility Society from February 2024. As a Strategic Advisor for Fertilidad Integral and Sama Fertility since January 2024 and July 2023 respectively, as well as for LEVY Health since October 2022, Cynthia contributes significantly to advancing fertility practices. Cynthia also serves as VP of Clinical Strategy and Executive Director of Embryology Strategy and Operations at TMRW Life Sciences, which pioneers automated fertility cryostorage solutions. Additionally, Cynthia is a Scientific Advisory Board Member at Hamilton Thorne, Inc. and the Founder/CEO of Cellavita LLC, providing management services in the fertility sector. Educational credentials include a Master of Science in Clinical Embryology from the University of Leeds and a Bachelor of Science from Springfield College.
This person is not in any teams
This person is not in any offices
Sama Fertility
17 followers
Studies show that most fertility patients will spend hundreds of hours on the road, back and forth to appointments. What’s more, some patients who live outside major metropolitan areas may not be able to receive care at all or will have to travel for weeks at a time. At Sama, we believe that fertility care is for everyone and should not come at the expense of wellbeing. When patients start their Sama journey, they get access to personalized, comprehensive care from the comfort of their own home—or wherever they may be. Remote monitoring allows our patients to continue to prioritize what’s important—work, family, travel—without compromising on convenience or care quality. At Sama, we ensure that your journey to parenthood is as convenient as it is successful, setting a new standard for what fertility care can and should be. Learn more at www.samafertility.com.